Back to Article
A Retrospective, Cross-sectional Hospital-based Study to Determine the Epidemiological, Clinical and Comorbidity Characteristics in Older Adults with Psoriasis
Global Journal of Epidemiology and Infectious Disease
| Vol 2, Issue 1
Table 5. Studies describing systemic comorbidities andPsoriasis.
| Year | Author | Country | Age grp(years) | Hypertension | Diabetes Mellitus type II | Dyslipidemia | Ischemic Heart Disease | Metabolic syndrome | |||||
| Psoriasis | Control | Psoriasis | Control | Psoriasis | Control | Psoriasis | Control | Psoriasis | Control | ||||
| 1985 | Henseler et al.44 | Germany | N/A | 1.9 | 0.8 | 2.1 | 1.1 | - | - | - | - | - | - |
| 2002 | Niemann et al.37 | USA | 20-90 | 34.7 | 11.9 | 11.5 | 3.3 | 10.7 | 3.3 | - | - | - | - |
| 2006 | Gelfand et al.35 | USA | 31-63 | 14.7 | 11.9 | 4.4 | 3.3 | 4.6 | 3.3 | 1.8 | 1.4 | - | - |
| 2012 | Mazlin et al.36 | Malaysia | > 18 | 33.2 | - | 17.7 | - | 17.8 | - | 5.8 | - | - | - |
| 2012 | Fernandez-Torres et al.17 | Spain | > 65 | 55.7 | - | 25.7 | - | 29 | - | - | - | - | - |
| 2015 | Takshita et al.26 | USA | 67.6 | - | 32.4 | - | 59.9 | - | 23.5 | - | - | - | |
| 2016 | Phan C et al.41 | France | 48.7 avg | 26.1 | - | 11 | - | 27.5 | - | - | - | - | - |
| 2018 | Feldman et al.45 | USA | >20 | 39.7 | 33.7 | 15.5 | 13 | 38.7 | 33 | 10.7 | 8.7 | - | - |
| 2018 | Kim et al.34 | South Korea | > 20 | 5 | 3.3 | - | - | - | - | - | - | - | - |
| 2020 | Yildizhan et al.16 | Turkey | ≥65 | 57.3 | - | 33.7 | - | 22.5 | - | 22.5 | - | - | - |
| 2020 | Our study | India | > 60 | 49.6 | 53.1 | 22.8 | 37 | 25.8 | 2.3 | 10.4 | 8.8 | 17.8 | 5.2 |